HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A pharmacological cost-effective analysis of vobenzim use in combined treatment of chronic prostatitis].

Abstract
A pharmacological cost-effective analysis of systemic enzymotherapy combination with fluoroquinolone antibiotics in the treatment of chronic bacterial prostatitis showed cost-effect of such therapy: medical cost efficacy of the treatment of chronic bacterial prostatitis with antibiotic + vobenzim is 2 times higher than of antibiotic treatment only.
AuthorsT N Moiseeva, V G Serpik, A Iu Kulikov
JournalUrologiia (Moscow, Russia : 1999) (Urologiia) 2011 May-Jun Issue 3 Pg. 31-5 ISSN: 1728-2985 [Print] Russia (Federation)
PMID21870481 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Fibrinolytic Agents
Topics
  • Adolescent
  • Adult
  • Chronic Disease
  • Costs and Cost Analysis
  • Fibrinolytic Agents (administration & dosage, economics)
  • Humans
  • Male
  • Middle Aged
  • Prostatitis (drug therapy, economics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: